Navigation Links
Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007
Date:10/4/2007

ended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to secure FDA approval for our product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology; the progress or success of our research, development and clinical programs, the initiation and completion of our clinical trials, the timing of the interim analyses and the timing or success of our product candidates, particularly VIAject(TM) and VIAtab(TM); our ability to secure patents for VIAject(TM) and our other product candidates; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. The Company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.

BIOD-G


'/>"/>
SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014  iVinci Health LLC, the company ... Revenue Management system, branded as VisitPay®, has successfully closed ... the launch of a new extension to VisitPay® – ... easy and convenient way for patients to manage their ... by them and their families. The new ...
(Date:9/15/2014)... 15, 2014 Applied Silicone Corporation, ... for the medical device and critical healthcare market, ... the implantable medical device market. The Dual ... delivering a silicone gel with improved fracture resistance, ... technology consists of two crosslinked networks working in ...
(Date:9/15/2014)... septiembre de 2014 La segunda anual International ... 12 al 18 de octubre. Como iniciativa conjunta de la ... compañías miembro s, la IPAW se ha diseñado para: ... a la colección de fuentes de plasma , Reconocimiento ... y mejorar las vidas , Aumento del conocimiento sobre ...
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
Breaking Biology Technology:iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... ... SAN FRANCISCO, Calif., Sept. 8 Proteolix, Inc., a,leader in ... pathways in cancer and autoimmune diseases, today,announced the successful completion ... round was led by new investor Nomura Phase4 Ventures.,New investor ...
... appointed A.J. Whalen as Solutions Director. , ... ... www.symphony-consulting.com [Symphony Management Consulting] announced that it has appointed ... joins Symphony from Wellesley Information Services (WIS) where he was ...
... of a study led by Yuntao Wu, assistant professor in ... community is one step closer to understanding how the human ... which is caused by HIV, affected more than 33 million ... , In the Sept. 5 issue of the journal ...
Cached Biology Technology:Proteolix Raises $79 Million in Series C Financing 2Proteolix Raises $79 Million in Series C Financing 3Symphony Managemnt Consulting Hires New Solutions Director 2Researchers decode viral process that prepares cells for HIV infection 2
(Date:9/15/2014)... -- Speed and agility are hallmarks of the cheetah: The ... to accelerate to 60 mph in just a few seconds. ... its legs in tandem, bounding until it reaches a full ... bounding that they,ve successfully implemented in a robotic cheetah ... that weighs about as much as its feline counterpart. The ...
(Date:9/15/2014)... in German . ... it doubles, divides in the middle and originates two ... that cells of the same kind are similarly sized ... University of Vienna, revealed that two non-model bacteria divide ... the naked eye. These findings have been published in ...
(Date:9/15/2014)... Philadelphia, PA, September 15, 2014 Schizophrenia is generally ... it shares many risk factors, both genetic and environmental, ... disability. , The normal path for brain development is ... of genes and a wide range of environmental factors. ... and patient populations are required in order to map ...
Breaking Biology News(10 mins):Run, cheetah, run 2Run, cheetah, run 3Think big! Bacteria breach cell division size limit 2Brain Development in Schizophrenia Strays from the Normal Path 2
... are published in the journal Nature Communications , on ... adults in France, and its constitutive mechanisms are still not ... is coordinated by a specialised part of the brain (the ... In this way, after a period of excessive food intake ...
... John Wiley & Sons, Inc., today announced that it will ... The EMBO Journal , EMBO reports and ... three leading scientific journals alongside EMBO Molecular Medicine , ... Journal is EMBO,s flagship title. Since its launch in ...
... damage is an important mechanism of glioma. X-ray cross-complementing ... participates in the base excision repair pathway. To date, ... between the XRCC1 polymorphisms and risk of cancers such ... of studies that focused on glioma is relatively small. ...
Cached Biology News:Obesity: A new appetite-increasing mechanism discovered 2Wiley and EMBO announce expanded partnership 2
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
... Orbital Shakers combine high durability and ... power. The patented triple-counterbalanced heavy-duty ... to run with heavy out-of-balance loads. ... reduces contamination. The heavy stainless ...
... T4 Polynucleotide Kinase (PNK) catalyzes ... ATP to the 5'-hydroxyl of single- ... 3'-monophosphates. The enzyme also removes the ... and deoxyribonucleoside 3', 5'-diphosphates to form ...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: